Top compounds associated with response to CT62


Feature Type Standardized
Nominal ANOVA
mRNA FQI-1 CTRPv2 pan-cancer AAC -0.054 0.3
mRNA Bosutinib GDSC1000 pan-cancer AAC -0.036 0.3
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.038 0.3
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.038 0.3
mRNA UNC0638 GDSC1000 pan-cancer AAC -0.031 0.3
mRNA dabrafenib GDSC1000 pan-cancer AAC 0.031 0.3
mRNA Bryostatin 1 GDSC1000 pan-cancer AAC 0.036 0.3
mRNA GW843682X GDSC1000 pan-cancer AAC -0.054 0.3
mRNA BIX-01294 CTRPv2 pan-cancer AAC -0.036 0.3
mRNA TG-100-115 CTRPv2 pan-cancer AAC -0.039 0.3
Download CSV